Stock Information

Regenxbio Inc (RGNX)

Ticker Symbol: RGNX

Exchange: NASDAQ

Sector: Biotechnology

Market Cap: $456.65 mil

Piotroski score: 4

PE Ratio: N/A

EPS (TTM): -3.7541

Revenue (TTM): $3.29 M

Dividend Yield: N/A%

ROE: -103.12%

Latest News

Regenxbio Enters Settlement And Release Agreement With GlaxoSmithKline On March 18, 2026; To Pay $10.0M To GlaxoSmithKline For Alleged Underpayment Of Sublicense Fees; Settlement Agreement Includes Mutual Releases Of Past And Certain Future Claims; To Continue To Pay GSK Amounts Received From Sublicensees Pursuant To Existing Sublicense Agreements
Fri, Mar 20, 2026 5:34 PM

Key Financials

Financial data not available

Bullican is the only breakout screener that every trader needs.

Contact

Social

Help

Address copied to clipboard!